Tag: #BECAR7

  • Untitled post 1832

    Base-Edited CAR T-Cell Therapy Achieves Remission in Refractory T-Cell Leukemia The therapeutic armamentarium against hematological malignancies has been substantially enriched through the clinical implementation of BE-CAR7, a pioneering base-edited chimeric antigen receptor T-cell therapy targeting T-cell acute lymphoblastic leukemia. Announced this December by investigators at University College London and Great Ormond Street Hospital, this therapeutic…